Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Aummune logo — WE ARE ALL UNIQUE SO IS AUMMUNE. The future of personalized...

Aummune

WE ARE ALL UNIQUE SO IS AUMMUNE. The future of personalized therapy for cancer

Founded 2017 Israel Israel 18 employees Biotechnology, Design +3

General Information

Company Name Aummune
Founded Year 2017
Location Israel Israel
Employees 18
Industries Biotechnology, Design, Health Care +2
Social

BounceWatch is an independent company data service, not affiliated with Aummune. To contact Aummune, visit aummune.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Aummune compare?

A PDF of Aummune and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Aummune soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Aummune

Aummune is an Israeli startup that aims to revolutionize the field of personalized therapy for cancer. The company's slogan, "WE ARE ALL UNIQUE SO IS AUMMUNE. The future of personalized therapy for cancer," reflects its commitment to individualized treatment. Aummune's groundbreaking approach involves the development of a first-of-its-kind individual drug-customization platform. This platform utilizes a unique efficacy-driven selection process to match and produce a patient-specific tri-functional aptamer drug that can safely and synergistically induce cancer cell death while activating both innate and adaptive immune responses. The concept of personalized therapy aligns with the growing trend in healthcare towards tailored treatments that consider each patient's unique genetic makeup and disease characteristics. As Aummune continues to advance its innovative platform, it has the potential to make significant contributions to the field of cancer treatment, offering new hope for patients and presenting an intriguing opportunity for venture capital investors.

Business keywords: personalized therapy, cancer treatment, drug customization, efficacy-driven, tri-functional aptamer drug, patient-specific, immune response, cancer cell death, innate immunity, adaptive immunity, oncology, precision medicine

No funding data available for Aummune yet.

Aummune Alternatives & Competitors

View All Alternatives
Aummune vs
Caedo Oncology AS
Caedo Oncology AS Norway

We create improved treatment options for cancer patients through unique immunotherapy opportunities

Venture round
6 employees
Biotechnology, Health Care
Aummune vs
Tango Therapeutics
Tango Therapeutics United States

Targeting tumor suppressor loss to unmask vulnerabilities for the next generation of precision medic...

Post-IPO Equity
157 employees
Biotechnology, Health Care
Aummune vs
TransCode Therapeutics, Inc.
TransCode Therapeutics, Inc. United States

Delivering a cancer-free future

Post-IPO Equity
11 employees
Biotechnology, Health Care
View all alternatives

FAQ About Aummune

WE ARE ALL UNIQUE SO IS AUMMUNE. The future of personalized therapy for cancer
Aummune was founded in 2017.
Aummune is headquartered in Israel.
Aummune operates in Biotechnology, Design, Health Care, Health and Wellness and Pharmaceutical. Its work centres on personalized therapy, cancer treatment, drug customization and efficacy-driven.
Aummune has approximately 18 employees.
Top alternatives and competitors to Aummune include Caedo Oncology AS, Tango Therapeutics, TransCode Therapeutics, Inc., Primmune Therapeutics, Kaio Therapy, LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Aummune and Caedo Oncology AS are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Aummune, https://bouncewatch.com/company/aummune, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes